Health Archive » November, 2006

Health - November, 2006

131 articles

• Saint Vincent Wants To Sell Unpaid Patient Claims
• Eli Lilly & Co. Sued By 105 Plaintiffs Over Zyprexa
• Drug-Coated Stents Face Further Scrutiny
• Miami Hospital Settles Kickback Charges For $15.4M
• Appeals Court Lets Biotech Patent Suit Proceed
• Scrushy Settles Claims Over Bonuses, Legal Fees
• Court Brings Suit Against Blue Cross Back To Life
• Merck Downplayed Vioxx Risks, Doctor Testifies
• Court Refuses To Toss Claims Against Medtronic
• UnitedHealth Shareholders: Freeze McGuire Assets
• Trial Starts In Pfizer's Norvasc Patent Dispute
• Cytosol Accosts Chubb For Insurance Money
• Machine Companies Settle Patent Suit
• FDA Fines Red Cross For Blood-Safety Violations
• World Health To Settle Class Action For $2.7M
• ITC To Review Smallpox Vaccine Ruling
• Hospital Sued For Sexual Harrassment, Retaliation
• Wyeth, Others Face New Hormone Replacement Suit
• Federal Circuit Denies Amgen's Rehearing Request
• Court Rejects J&J Bid For Injunction In Amgen Case
• Uninsured Patients' Class Action Gets Green Light
• Judge Rules Vioxx Claims Should Be Tried Separately
• Whistleblowers Propel Government Fraud Recoveries
• Tenet Healthcare Settles Most Of Tax Case With IRS
• State Attorney General Probes Off-Label Actiq Use
• Cancer Vaccine Co. Files For Chapter 7
• Ruling Favors Scrushy In Probe Into Juror Behavior
• Court Snubs Last-Ditch Motion In Univasc Suit
• Federal Circuit Boosts Impax In Aventis Patent Suit
• Teva To Pay Up To $70M To Settle With Pfizer
• New Cyberonics Chairman Probed For Backdating
• Bush Nominee For Family Planning Continues To Rankle
• Orthopedic Company Comes Under SEC Scrutiny
• FDA May Speed Drug Ad Review For Fee
• Judge Grants Class Status To Mentally Ill Plaintiffs
• Appeals Court Revives Patent Suit Over Spinal Screws
• Patients Cannot Sue Doctors Under HIPAA, Court Rules
• The Massachusetts Health Care Reform Act's Health Insurance Nondiscrimination Rule
• Catheter Maker Settles Antitrust Suit
• Another Republican Vows To Block FDA Confirmation
• Pharmaceutical Giants Face Wage And Hour Claims
• Human Error or Criminal Conduct – How Can One Tell the Difference?
• Drinker Biddle To Gain Top Health Care Group In Merger
• Pfizer Hardens Stance Over Chinese Viagra
• Novo Nordisk Sues USPTO Over AERx Applications
• Saint Vincent Granted Extension Of Exclusive Rights
• Inverness Patent Saga Ends In Multimillion-Dollar Pact
• Biovail CEO Tries To Muscle Back Into Bankruptcy Case
• Alcon Sues Apotex To Block Generic Eye Drug
• Federal Circuit Upholds Patent Ruling In Diprivan Case
• Interference Proceeding Ordered In DNA Tech Spat
• New Rules Addressing Physician Payment And Outpatient Procedures On Public Display
• City Sues Kaiser For Dumping Patients On Streets
• Solutia Supports Extension Bid
• Immune Response Settles Shareholder Suits
• Generics Maker Settles Imitrex Suit With Glaxo
• FDA Eyes Sanofi Antibiotic Over Safety Concerns
• Dusa Sues Chemical Co. Over Skin Treatment Patents
• Jury Gives Merck Another Vioxx Win
• Saint Vincent Seeks Extension of Ch. 11 Plan
• Sales Rep Challenges Eli Lilly For Unpaid Overtime
• Monsanto Fires Back At Solutia Noteholders
• Synergetics Starts A Battle In Eye Surgery Patent War
• NYC's Bid To Halt Health Insurance Cos. Merger Denied
• Companies Settle Patent Suit Over Vascular Product
• Omnicare Settles Fraud Charges For $49.5M
• Data Exclusivity Rules Rile Canadian Generics Makers
• San Francisco Trade Group Sues Over Health Care Law
• Warner Chilcott Calls Truce Over Birth Control Drug
• Medical Device Co. Pokes Bayer With Suit Over Lancets
• U.S. Appeals Court Upholds Generic Zocor's Exclusivity
• Can Nonprofit Hospitals Coexist With Physician Ownership?
• Court Scraps Counterclaims Against J&J Unit
• Shire Unit Asserts Adderall Patents Against Andrx
• Stryker Wins Second Round In Bout With Acumed
• Spectrum Settles With Glaxo Over Imitrex
• Jury Awards Blind Boy $20M In Negligence Case
• Vioxx Class Action Approved In Quebec
• Former Yale Scientist Says She's Lost Out On Royalties
• SeraCare Agrees To Shareholder's Chapter 11 Plan
• Crowell Snags Health & Employment Boutique
• Metabolife Forks Over $56M In Ephedra Settlement
• Judge Unmoved By Brockovich's Latest Campaign
• Hypertension Patients Join Feud Over Pfizer's Norvasc
• FDA To Up Postmarket Regulation Of Medical Devices
• Democrats Take Control, Look To Reform Drug Laws
• FTC Probes Adderall Settlement Between Barr, Shire
• Advocates Can Subpoena White House In Plan B Suit
• Abbott's Ultane Patent Declared Invalid
• Aetna In Hot Water Over Anorexia Coverage
• Pharma Stalls U.S., Korean Free Trade Talks
• Jury Rejects Doctor's Claim Over Genentech Drug
• Shareholders Rebel Against Connetics
• Hospital Co. Settles Shareholder Suits Over Merger
• California Work-At-Home Employees Sue Cigna Healthcare
• Claimants Push To Remove Saint Vincent's Stay
• Teva Motions Denied In Patent Spat With Pfizer
• Bradley Pharmaceuticals Derivative Action Dismissed
• Pfizer Attacked Over Lipitor Licensing Pact
• Stryker CEO Says DOJ Should End Price-Fixing Probe
• Merck Riled In Tax Dispute With U.S. And Canada
• Martha Stewart's Co. To Settle ImClone Suit For $30M
• Generic Allegra To Remain On The Market
• QLT Liable For Unfair Trade In Visudyne Litigation
• Jury Awards Mother $15M In Medical Negligence Case
• Appeals Court Grants EEOC Win Against Nursing Home
• Judge To Consider If Jurors Broke Rules In Scrushy Case
• High Court Ask DOJ To Weigh In On Damages
• Apotex' Antitrust Claims In Patent Case Approved
• McKesson Executives Dodge Conspiracy Bullet
• FDA Warns Bausch & Lomb After Plant Inspection
• Health Labor Lawyer Joins Epstein Becker & Green
• Baxter Healthcare Worker's Claims Tossed
• Antitrust Suit Claims Eisai Duped Patent Agency
• Eli Lilly Receives Subpoena Over Zyprexa
• CV Therapeutics Offers $13.5M In Settlement Agreement
• Court Denies J&J Unit's Motion In Spinal Screw Suit
• Pharmaceutical Giants, Consumers Spar As Trial Looms
• Cyberonics Shareholder Pushes For Annual Meeting
• Ortho-McNeil Faces More Suits Over Contraceptive
• CVS-Caremark Merger Creates Antitrust Complications
• Israeli Researchers Want ImClone To Pay Royalties
• Genentech Backtracks In Synagis Dispute
• Warner Chilcott Hit With Suit Over IPO Prospectus
• As Prices Are Slashed, Drug Makers Eye German Law
• Amerigroup To Fight Back Against $144M Verdict
• Groups Spar Over Medical Assistant Certification
• Glaxo Agrees To Settle Paxil Litigation For $63.8M
• Abortion Records Given To Kansas Attorney General
• Judge Trebles Invitrogen's Cash Award
• Supreme Court Denies Ferring B.V.'s Petition